Simpson, E.; Merola, J.; Silverberg, J.; Zachariae, R.; Olsen, R.; Wollenberg, A. Safety of Specifically Targeting Interleukin 13 With Tralokinumab in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-Blind, Placebo-Controlled Phase 3 and Phase 2 Trials. J of Skin 2021, 5, s11.